Filed in archive
Diagnostics, Methodologies and Instrumentation
by ruth on October 16, 2006
The CA1-18 test is a monoclonal-polyclonal sandwich EIA for the quantitative measurement of CA1-18 (Tennessee Antigen) in human serum. Tennessee Antigen, a tumor-associated antigen, is present in elevated levels in the serum of patients with various carcinomas, particularly colorectal cancer.
The diagnostic test is now available to research customers, and DP plans to submit the CA1-18 EIA to the U.S. Food and Drug Administration (FDA) for marketing clearance in April 2007.
Source: MarketWire
[Image: See larger version from EDP Biotech]
Tags:
diagnostics
colon+cancer
cancer
colorectal+cancer
immunoassay
biotech
early+detection
marker+assay
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/39226
Addthis
Ask
Blinklist
del.icio.us
Digg
Fark
Facebook
Google
Lycos
Ma.gnolia
Mr Wong
Netscape
Netvousz
Newsvine
Reddit
StumbleUpon
Slashdot
Tailrank
Technorati
Wink
Yahoo
Vote for CA1-18 Tumor Marker Assay for Early Detection and Diagnosis of Colorectal Cancer:
|
Rating: 5.00 out of 5 vote(s) cast.
|
Response from:
Trusted.MD Network
The American Cancer Society (ACS) has launched an online video community called SharingHope.tv.
A lot like YouTube, but the essence is that, it is a venue where cancer patients, survivors and their families can share their stories, triumphs, as well as
Response from:
Trusted.MD Network
Subscribe
Use the search to look for other interesting posts
| RSS |  See all blog subscribe options |
 What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |
